Private Markets, Angel and Secondary Investing, Sacra

Sacra

Private Markets, Angel and Secondary Investing

Bringing transparency to private markets so investors, founders, and employees can build on conviction. Sacra delivers deeply researched insights on the private companies shaping tomorrow's markets. By surfacing the data, context, and operator perspective that are missing from private markets today, we help secondary buyers and sellers price equity accurately and unlock liquidity for the people building these businesses.

Private Capital Markets

<ul><li>Sacra estimates Epic hit $5.7B in revenue in 2024, up 16% from $4.9B in 2023.</li><li>The company maintains high profitability with estimated EBITDA margins above 30% and operates debt-free.</li><li>Epic's AI Charting tool listens during patient visits, drafts the clinician note, and queues suggested orders based on the conversation that clinicians must review before placement.</li></ul>

Sacra estimates Epic hit $5.7B in revenue in 2024, up 16% from $4.9B in 2023.The company maintains high profitability with estimated EBITDA margins above 30% and operates debt-free.Epic's AI Charting tool listens during patient visits, drafts the clinician note, and queues suggested orders based on the conversation that clinicians must review before placement.

<ul><li>Sacra estimates Commure hit $105M in annual recurring revenue in March 2024, growing 150% YoY.</li><li>In May 2026, Commure raised $70M led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland &amp; Ellis, at a $7B post-money valuation.</li><li>Commure has tailwinds from the massive shift toward AI-enabled healthcare automation and has the opportunity to expand into adjacent markets beyond its current focus on clinical documentation and revenue cycle management.</li></ul>

Sacra estimates Commure hit $105M in annual recurring revenue in March 2024, growing 150% YoY.In May 2026, Commure raised $70M led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland &amp; Ellis, at a $7B post-money valuation.Commure has tailwinds from the massive shift toward AI-enabled healthcare automation and has the opportunity to expand into adjacent markets beyond its current focus on clinical documentation and revenue cycle management.

Infinite Reality / Private Capital Markets

<ul><li>Infinite Reality’s last confirmed, verified valuation stands at $5.1 billion, established in July 2024 following a $350 million equity round from a private family office.</li><li>In November 2025, Infinite Reality—newly rebranded as Napster—disclosed to shareholders that the multi-billion dollar capital infusion would not materialize, stating they were the victim of an intricate financial hoax.</li><li>The enterprise metaverse market is projected to reach $1 trillion by 2030, driven by demand for virtual training, digital twins, and remote collaboration.</li></ul>

Infinite Reality’s last confirmed, verified valuation stands at $5.1 billion, established in July 2024 following a $350 million equity round from a private family office.In November 2025, Infinite Reality—newly rebranded as Napster—disclosed to shareholders that the multi-billion dollar capital infusion would not materialize, stating they were the victim of an intricate financial hoax.The enterprise metaverse market is projected to reach $1 trillion by 2030, driven by demand for virtual training, digital twins, and remote collaboration.

<ul><li>Quartet made an estimated $49.7M in 2021, an increase of 50% over 2020.</li><li>Quartet Health has raised $214M from investors such as GV, Deerfield Capital, Centene Corporation, and Oak HC/FT.</li><li>Quartet is available in only eight states, compared to Cerebral and Amazon Care, which are in all 50 states.</li></ul>

Quartet made an estimated $49.7M in 2021, an increase of 50% over 2020.Quartet Health has raised $214M from investors such as GV, Deerfield Capital, Centene Corporation, and Oak HC/FT.Quartet is available in only eight states, compared to Cerebral and Amazon Care, which are in all 50 states.

<ul><li>Tala Health raised $100 million in a seed round in November 2025 at a $1.2 billion post-money valuation.</li><li>The platform generates value by shifting a significant portion of patient touchpoints to autonomous or semi-autonomous AI agents, improving unit economics compared to human-only care coordination.</li><li>Tala can extend its multi-agent architecture into disease-specific clinical decision support tools for cardiology, dermatology, and oncology.</li></ul>

Tala Health raised $100 million in a seed round in November 2025 at a $1.2 billion post-money valuation.The platform generates value by shifting a significant portion of patient touchpoints to autonomous or semi-autonomous AI agents, improving unit economics compared to human-only care coordination.Tala can extend its multi-agent architecture into disease-specific clinical decision support tools for cardiology, dermatology, and oncology.

United States

Healthcare software suite for electronic health records, patient portals, and revenue management

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Epic (EPIC US)

Primer: Epic - 09 Feb 2026

Healthcare software suite for electronic health records, patient portals, and revenue management

Sacra

Primer: Commure - 16 Jul 2026

Software suite for hospitals combining EHR, billing, patient monitoring, and communication tools

Sacra

Primer: Infinite Reality - 14 Jul 2026

Tool for brands to build and manage immersive 3D environments and virtual stores

Sacra

Primer: Quartet Health - 27 Feb 2026

Care navigation software connecting patients to mental health providers through health plans and systems

Sacra

Primer: Tala Health - 09 Nov 2025

AI-driven healthcare platform integrating proprietary AI agents with licensed clinicians to provide patient-centric care

Sacra

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)